Exsilio Therapeutics Funding & Investors
Boston, MA
Exsilio's method is based on naturally occurring genetic elements that can accurately insert new genes into cells via RNA intermediate templates. Exsilio employs predictive in-silico modeling and wet lab-based experiments to create such elements for accurate insertion of therapeutic genes into safe harbor regions of disease-relevant cells.
exsiliotx.comTotal Amount Raised: $82,000,000
Exsilio Therapeutics Funding Rounds
Series A
$82,000,000
Series A Investors
Delos CapitalNovartis Venture FundOrbiMed AdvisorsCRISPR TherapeuticsInsight PartnersInvus GroupInnovation EndeavorsJPMorgan ChaseDeep-InsightDeep InsightArc Ventures
Funding info provided by Diffbot.